Data from multiple sources - Curated by Marshall Pearce - Last updated 06 June 2017

Latest news articles

Added 4 months ago Drug news

FDA approves Vabomere (meropenem + vaborbactam) (formerly Carbavance) to treat urinary tract infections.-Rempex Pharmaceuticals/The Medicines Company.

The FDA approved Vabomere (meropenem + vaborbactam)( formerly Carbavance),from Rempex Pharmaceuticals, for adults with complicated urinary tract infections (cUTI), including...

Added 9 months ago Drug news

Zolyd (fosfomycin for injection) meets primary endpoint in pivotal phase II/III trial in complicated urinary tract infections- Zavante Therapeutics

Zavante Therapeutics announced that Zolyd (fosfomycin for injection, also known as ZTI-01), met the primary endpoint of statistical non-inferiority to...

Added 11 months ago Drug news

FDA approves sNDA for AVYCAZ (ceftazidime and avibactam) in complicated urinary tract infections (cUTI), including pyelonephritis- Allergan

Allergan announced the FDA has approved the company's supplemental New Drug Application (sNDA) to update the label for AVYCAZ (ceftazidime...

Search all news articles for Urinary tract infections

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Acute and Advanced Heart Failure

Acute and Advanced Heart Failure

What are the most effective treatments for acute heart failure? Can you define advanced heart failure? Discover here...

+ 3 more



Epidemiology, pathophysiology, diagnosis/treatment guidelines, recent publication summaries and more.

+ 1 more

Load more


Guidelines on Urological Infections

Due to the increasing threat of resistant pathogens worldwide, it has become imperative to limit the use of antibiotics, and...

Added 1 year ago

2015 UK National Guideline on the management of non-gonococcal urethritis

We present the updated British Association for Sexual Health and HIV guideline for the management of non-gonococcal urethritis in men....

Added 2 years ago

The Initial Management of Chronic Pelvic Pain

The purpose of this guideline is to provide an evidence-based summary for the generalist to facilitate appropriate investigation and management...

Added 5 years ago

Search all guidelines for Urinary tract infections

Journal articles

Ceftazidime/avibactam: a novel cephalosporin/nonbeta-lactam beta-lactamase inhibitor for the treatment of complicated urinary tract infections and complicated intra-abdominal infections.

There has been greater interest in developing additional antimicrobial agents due to the increasing health care costs and resistance resulting from bacterial pathogens to currently available treatment options.

Added 9 months ago

Ceftolozane/tazobactam and ceftazidime/avibactam: two novel β-lactam/β-lactamase inhibitor combination agents for the treatment of resistant Gram-negative bacterial infections.

The rise in resistant Gram-negative bacteria is a major concern and has led to difficulty in treating multidrug-resistant (MDR) infections....

Added 2 years ago

Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI).

BACKGROUND: Treatment of complicated urinary-tract infections is challenging due to rising antimicrobial resistance. We assessed the efficacy and safety of...

Added 2 years ago

Search all journal articles for Urinary tract infections


Urinary tract infection

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
Registration required
Subscription fee
Search all CME for Urinary tract infections